Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026)
Phibro Animal Health (PAHC) posted Interest & Investment Income of -$10.2 million for Q2 2026, up 2.38% on a QoQ basis from -$10.4 million in Q1 2026, and down 18.27% year-over-year from -$12.5 million in Q2 2025.
Powered by 
Analysis
Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026) Analysis & Trends
Phibro Animal Health has reported Interest & Investment Income for 9 years, with the latest figure at -$10.2 million in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 18.27% year-over-year to -$10.2 million in Q2 2026; TTM through Jun 2026 was -$44.4 million, a 28.4% decrease from a year earlier, with the FY2026 full-year figure at -$44.4 million, down 28.4% from the prior year.
- Interest & Investment Income was -$10.2 million for Q2 2026 at Phibro Animal Health, up from -$10.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was -$4.6 million in Q3 2023, with the low at -$12.1 million in Q3 2025.
- Average Interest & Investment Income over 4 years is -$8.1 million, with a median of -$8.8 million recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income sank 104.48% in 2025, then declined 11.5% in 2026.
- Over 4 years, Interest & Investment Income stood at -$4.7 million in 2023, then sank by 93.09% to -$9.0 million in 2024, then plunged by 30.68% to -$11.8 million in 2025, then rose by 13.38% to -$10.2 million in 2026.
- The last three Interest & Investment Income figures came in at -$10.2 million (Q2 2026), -$10.4 million (Q1 2026), and -$11.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.82 Bn | 40.62 Bn | 779.09 Mn | 606,000.00 |
| 2 | Zoetis | 30.60 Bn | 28.92 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.86 Bn | 11.33 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | -10.18 Mn |
| 5 | Immucell | 88.88 Mn | 80.02 Mn | 2.44 Mn | 65,343.00 |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.18 Mn |
| Mar 31, 2026 | -10.43 Mn |
| Dec 31, 2025 | -11.76 Mn |
| Sep 30, 2025 | -12.06 Mn |
| Jun 30, 2025 | -8.61 Mn |
| Mar 31, 2025 | -9.36 Mn |
| Dec 31, 2024 | -9.00 Mn |
| Sep 30, 2024 | -7.64 Mn |
| Jun 30, 2024 | -4.74 Mn |
| Mar 31, 2024 | -4.58 Mn |
| Dec 31, 2023 | -4.66 Mn |
| Sep 30, 2023 | -4.56 Mn |
| Mar 31, 2016 | -4.27 Mn |
| Dec 31, 2015 | -3.97 Mn |
| Sep 30, 2015 | -3.82 Mn |
| Jun 30, 2015 | 10.86 Mn |
| Mar 31, 2015 | -3.60 Mn |
| Dec 31, 2014 | -3.52 Mn |
| Sep 30, 2014 | -3.49 Mn |
| Jun 30, 2014 | -59,000.00 |